Stay updated on VinMetAtezo: Stage IV NSCLC Clinical Trial
Sign up to get notified when there's something new on the VinMetAtezo: Stage IV NSCLC Clinical Trial page.

Latest updates to the VinMetAtezo: Stage IV NSCLC Clinical Trial page
- ChecktodayNo Change Detected
- Check8 days agoChange DetectedThe web page has been updated from version 2.15.0 to version 2.15.2.SummaryDifference0.1%
- Check15 days agoNo Change Detected
- Check22 days agoChange DetectedThe page has undergone significant content changes, including the removal of detailed information about treatment options for advanced non-small cell lung cancer (NSCLC) and the addition of a new interventional model description for a clinical trial involving Vinorelbine and Atezolizumab.SummaryDifference33%
- Check29 days agoChange DetectedThe web page has been updated from version 2.14.3 to version 2.14.4.SummaryDifference0.1%
- Check59 days agoChange DetectedThe name 'Groupe Francais De Pneumo-Cancerologie' has been added, replacing the previous name 'Groupe Français de Pneumo-Cancérologie'.SummaryDifference0.2%
- Check73 days agoChange DetectedThe page has removed a notice regarding heavy traffic affecting the performance and availability of some NLM-NCBI services and products.SummaryDifference1%
- Check87 days agoChange DetectedThe page now includes a notice regarding heavy traffic affecting the performance and availability of some NLM-NCBI services and products, along with contact information for assistance.SummaryDifference1%
Stay in the know with updates to VinMetAtezo: Stage IV NSCLC Clinical Trial
Enter your email address, and we'll notify you when there's something new on the VinMetAtezo: Stage IV NSCLC Clinical Trial page.